By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ContraFect Corporation 

28 Wells Avenue, Third Floor

Yonkers  New York   10701  U.S.A.
Phone: 914-207-2300 Fax: n/a



Company News
ContraFect (CFRXU) CSO Steps Down 9/19/2016 7:37:42 AM
ContraFect (CFRXU) CEO to Retire, Will Relocate HQ from New York to Massachusetts 3/22/2016 5:44:34 AM
ContraFect (CFRXU) To Present At 27th Annual Piper Jaffray Healthcare Conference 12/1/2015 12:54:14 PM
ContraFect (CFRXU) Announces Third Quarter 2015 Financial And Operating Results 11/13/2015 1:03:08 PM
ContraFect (CFRXU) To Announce Third Quarter 2015 Results On November 12, 2015 11/9/2015 2:35:27 PM
ContraFect (CFRXU) To Present At 14th Annual BIO Investor Forum 10/14/2015 4:24:34 PM
ContraFect (CFRXU) Appoints Clinical Development Leader, Cara Cassino, M.D., As Chief Medical Officer 9/16/2015 12:19:10 PM
ContraFect (CFRXU) Announces Poster Presentation At The ICAAC/ICC 2015 Meeting For CF-301 For The Treatment Of Staph Aureus Infections, Including MRSA 9/9/2015 12:44:07 PM
ContraFect (CFRXU) Appoints Key Business Executives 9/8/2015 12:16:53 PM
FDA Grants Fast Track Designation To ContraFect (CFRXU)'s CF-301, The First Of Its Lysins, Currently In Development For The Treatment Of Staph Aureus Infections, Including MRSA 8/17/2015 11:19:53 AM